BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34768245)

  • 1. Further investigation of 3D dose verification in proton therapy utilizing acoustic signal, wavelet decomposition and machine learning.
    Yao S; Hu Z; Xie Q; Yang Y; Peng H
    Biomed Phys Eng Express; 2021 Nov; 8(1):. PubMed ID: 34768245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility study of range verification based on proton-induced acoustic signals and recurrent neural network.
    Yao S; Hu Z; Zhang X; Lou E; Liang Z; Wang Y; Peng H
    Phys Med Biol; 2020 Nov; 65(21):215017. PubMed ID: 32726760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical Note: Machine learning approaches for range and dose verification in proton therapy using proton-induced positron emitters.
    Li Z; Wang Y; Yu Y; Fan K; Xing L; Peng H
    Med Phys; 2019 Dec; 46(12):5748-5757. PubMed ID: 31529506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility study of 3D time-reversal reconstruction of proton-induced acoustic signals for dose verification in the head and the liver: A simulation study.
    Yu Y; Qi P; Peng H
    Med Phys; 2021 Aug; 48(8):4485-4497. PubMed ID: 34120348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A machine learning framework with anatomical prior for online dose verification using positron emitters and PET in proton therapy.
    Hu Z; Li G; Zhang X; Ye K; Lu J; Peng H
    Phys Med Biol; 2020 Sep; 65(18):185003. PubMed ID: 32460246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of patient-specific dose verification in proton therapy utilizing positron emission tomography (PET) and generative adversarial network (GAN).
    Ma S; Hu Z; Ye K; Zhang X; Wang Y; Peng H
    Med Phys; 2020 Oct; 47(10):5194-5208. PubMed ID: 32772377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-stage ionoacoustic range verification leveraging Monte Carlo and acoustic simulations to stably account for tissue inhomogeneity and accelerator-specific time structure - A simulation study.
    Patch SK; Hoff DEM; Webb TB; Sobotka LG; Zhao T
    Med Phys; 2018 Feb; 45(2):783-793. PubMed ID: 29159885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning based oxygen and carbon concentration derivation using dual-energy CT for PET-based dose verification in proton therapy.
    Liu Y; Zhou L; Peng H
    Med Phys; 2022 May; 49(5):3347-3360. PubMed ID: 35246842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation studies of time reversal-based protoacoustic reconstruction for range and dose verification in proton therapy.
    Yu Y; Li Z; Zhang D; Xing L; Peng H
    Med Phys; 2019 Aug; 46(8):3649-3662. PubMed ID: 31199511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic-based proton range verification in heterogeneous tissue: simulation studies.
    Jones KC; Nie W; Chu JCH; Turian JV; Kassaee A; Sehgal CM; Avery S
    Phys Med Biol; 2018 Jan; 63(2):025018. PubMed ID: 29176057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical detection threshold of the proton-acoustic range verification technique.
    Ahmad M; Xiang L; Yousefi S; Xing L
    Med Phys; 2015 Oct; 42(10):5735-44. PubMed ID: 26429247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Range and dose verification in proton therapy using proton-induced positron emitters and recurrent neural networks (RNNs).
    Liu C; Li Z; Hu W; Xing L; Peng H
    Phys Med Biol; 2019 Sep; 64(17):175009. PubMed ID: 31342940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionoacoustic characterization of the proton Bragg peak with submillimeter accuracy.
    Assmann W; Kellnberger S; Reinhardt S; Lehrack S; Edlich A; Thirolf PG; Moser M; Dollinger G; Omar M; Ntziachristos V; Parodi K
    Med Phys; 2015 Feb; 42(2):567-74. PubMed ID: 25652477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D
    Jiang Z; Sun L; Yao W; Wu QJ; Xiang L; Ren L
    Phys Med Biol; 2022 Oct; 67(21):. PubMed ID: 36206745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose calculation in proton therapy using a discovery cross-domain generative adversarial network (DiscoGAN).
    Zhang X; Hu Z; Zhang G; Zhuang Y; Wang Y; Peng H
    Med Phys; 2021 May; 48(5):2646-2660. PubMed ID: 33594673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton beam characterization by proton-induced acoustic emission: simulation studies.
    Jones KC; Witztum A; Sehgal CM; Avery S
    Phys Med Biol; 2014 Nov; 59(21):6549-63. PubMed ID: 25322212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the robustness of multilateration of ionoacoustic signals for localization of the Bragg peak at pre-clinical proton beam energies in water.
    Kalunga R; Wieser HP; Dash P; Würl M; Riboldi M; Schreiber J; Assmann W; Parodi K; Lascaud J
    Phys Med Biol; 2023 May; 68(10):. PubMed ID: 37011627
    [No Abstract]   [Full Text] [Related]  

  • 18. Benchmarking a GATE/Geant4 Monte Carlo model for proton beams in magnetic fields.
    Padilla-Cabal F; Alejandro Fragoso J; Franz Resch A; Georg D; Fuchs H
    Med Phys; 2020 Jan; 47(1):223-233. PubMed ID: 31661559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent dose verification system with Monte Carlo simulations using TOPAS for passive scattering proton therapy at the National Cancer Center in Korea.
    Shin WG; Testa M; Kim HS; Jeong JH; Lee SB; Kim YJ; Min CH
    Phys Med Biol; 2017 Sep; 62(19):7598-7616. PubMed ID: 28809759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single pulse protoacoustic range verification using a clinical synchrocyclotron.
    Caron J; Gonzalez G; Pandey PK; Wang S; Prather K; Ahmad S; Xiang L; Chen Y
    Phys Med Biol; 2023 Feb; 68(4):. PubMed ID: 36634371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.